NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹41 Cr | ₹20 Cr | ₹50 Cr | ₹57 Cr | ₹811,693 Cr |
What is the latest Consolidated Net Profit of NGL FINECHEM ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹41 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹50 Cr |
| Mar2022 | ₹57 Cr |
| Mar2021 | ₹811,693 Cr |
How is Consolidated Net Profit of NGL FINECHEM Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹41 Cr | 101.67 | |
| Mar2024 | ₹20 Cr | -59.05 | |
| Mar2023 | ₹50 Cr | -11.91 | |
| Mar2022 | ₹57 Cr | -99.99 | |
| Mar2021 | ₹811,693 Cr | - | |
Compare Consolidated Net Profit of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,455.0 Cr | 3.8% | 0.8% | 100.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 3.8% |
0.8% |
100.3% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses